Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application and expression of NR4A2 gene in pituitary adenoma biomarker

A 1. NR4A2, pituitary adenoma technology, applied in the field of use of natural ribonucleotides, can solve the problems of fast growth of tumor residual tissue, poor tumor curative effect, limited radiotherapy sensitivity, etc.

Inactive Publication Date: 2018-06-29
THE SECOND HOSPITAL OF DALIAN MEDICAL UNIV
View PDF6 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Invasive growth makes it difficult to completely remove the tumor by surgery, and the commonly used drugs bromocriptine and somatostatin have poor curative effects on this type of tumor; invasive growth also limits its sensitivity to radiotherapy, and radiotherapy in the sellar region is easy Damage to important structures such as the normal pituitary gland, hypothalamus, and optic nerve
These factors lead to high postoperative recurrence rate and rapid growth of tumor residual tissue in aggressive pituitary adenomas

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application and expression of NR4A2 gene in pituitary adenoma biomarker
  • Application and expression of NR4A2 gene in pituitary adenoma biomarker
  • Application and expression of NR4A2 gene in pituitary adenoma biomarker

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0017] The following will clearly and completely describe the technical solutions in the embodiments of the present invention with reference to the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only some, not all, embodiments of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention. The present invention will be further described below in conjunction with specific embodiment

[0018] 1. Experimental materials, clinical samples: tissue samples of 19 cases of pituitary adenoma (8 cases of invasive pituitary adenoma, 9 cases of non-invasive pituitary adenoma) were provided by the Second Affiliated Hospital of Dalian Medical University.

[0019] Reagents: NR4A2 screening primers were synthesized by Invitrogen; RNAiso Plus (product number 9109) ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application and an expression of an NR4A2 gene in a pituitary adenoma biomarker, in particular to the technical field of applications of natural ribonucleotide. An NR4A2 gene belongs to an orphan nuclear receptor subfamily in a nuclear receptor family and is used for identifying an object probably suffering from pituitary adenoma or invasiveness of pituitary adenoma. Theexpression of NR4A2 from a pituitary adenoma tissue sample of the object is detected, wherein NR4A2 with higher expression shows that the invasiveness of the pituitary adenoma of the object is high and is related with increase of the possibility of bad prognosis of the object. The invention provides the application of the NR4A2 gene. The expressions of the NR4A2 gene in tissue of invasive pituitary adenoma and non-invasive pituitary adenoma patients are different, and therefore, the NR4A2 gene has the application prospects of becoming the pituitary adenoma biomarker.

Description

technical field [0001] The present invention relates to the application of NR4A2 gene in biomarkers of pituitary adenoma, specifically the technical field of application of natural ribonucleotides. Background technique [0002] Pituitary adenoma (pituitary tumor for short) is one of the most common intracranial tumors in humans, accounting for about 10%-15% of intracranial tumors. Pituitary tumors are benign tumors histologically, but some pituitary tumors grow aggressively, enveloping or invading the surrounding tissue structure, and it is difficult to completely remove this part of the tumor, which is one of the main reasons for tumor recurrence. According to the biological behavior of pituitary tumors, they can be divided into non-invasive pituitary tumors, invasive pituitary tumors and pituitary carcinomas. Invasive pituitary tumors are between non-invasive pituitary tumors and pituitary carcinomas. Their histological appearance is benign, but their biological character...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/6886
CPCC12Q1/6886C12Q2600/118C12Q2600/158
Inventor 张波娄佳成王翔李欣宇吕逸竹郝宇超
Owner THE SECOND HOSPITAL OF DALIAN MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products